InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: changes_iv post# 42765

Sunday, 10/10/2021 11:25:59 PM

Sunday, October 10, 2021 11:25:59 PM

Post# of 44690
Our development of ZYESAMI is based on intellectual property licensed to us by the Research Foundation of the State University of New York. We have a commercial partnership with Relief Therapeutics Holdings, SA and its wholly owned subsidiary Therametrics Discovery AG (collectively, “Relief Therapeutics”) in which we and Relief Therapeutics have agreed to share profits from ZYESAMI for certain indications, based on Relief Therapeutics’ funding of our development efforts.